The peptide angiotensin IV (Ang IV) is a derivative of angiotensin II. While insulin regulated amino peptidase (IRAP) has been proposed as a potential receptor for Ang IV, the signalling pathways of Ang IV through IRAP remain elusive. We applied high-resolution mass spectrometry to perform a systemic quantitative phosphoproteome of Neura-2A (N2A) cells treated with and without Ang IV using sta ble-isotope labeling by amino acids in cell culture (SILAC), and identifi ed a reduction in the phosphorylation of a major Ser/Thr protein phosphorylase 1 (PP1) upon Ang IV treatment. In addition, spinophilin (spn), a PP1 regulatory protein that plays important functions in the neural system, was expressed at higher levels. Immunoblotting revealed decreased phosphorylation of p70S6 kinase (p70
INTRODUCTION
Angiotensin IV (Ang I V), a hexapeptide metabolite of Ang II, has drawn considerable attention because of its effect on regulating the process of learning and memory. Albiston identifi ed the Ang IV receptor in bovine adrenal membranes to be insulin-regulated aminopeptidase (IRAP) (Albiston et al., 2001) . Ang IV inhibits IRAP catalytic activity by binding to the catalytic site of IRAP (Lew et al., 2003) . Ang IV can facilitate memory in both normal (Braszko et al., 1988; Lee et al., 2004 ) and memory-compromised rodents (Wright et al., 1999) . Studies on the mechanism of Ang IV action over recent decades have shown that Ang IV has effects on increasing the intracellular calcium level (Dostal et al., 1990; Dulin et al., 1995; Chansel et al., 2001; Handa, 2001 ), regulating the proliferation of different tissue cells, and on glucose uptake in insulin responsive tissues and the brain (Fernando et al., 2008) . However, the exact mechanism by which Ang IV enhances memory remains to be elucidated.
Protein phosphorylase 1 (PP1) is a major protein Ser/Thr phosphatase. It is ubiquitously expressed in all eukaryotic cells, and plays important roles in a wide range of cellular processes, including meios is and cell division, apoptosis, protein synthesis, metabolism, cytoskeletal reorganization, and the regulation of membrane receptors and channels (Fernandez et al., 1992; Cheng et al., 2000; Wang et al., 2011) . Several isoforms of PP1, PP1α, PP1β and PP1γ, are known in mammals. These various isoforms are highly similar and ubiquitously expressed, except for the testis-enriched PP1γ 2 . PP1 can be regulated by inhibitory subunits that directly suppress its activity (Takai et al., 1987; Bialojan and Takai, 1988) , and by many regulatory subunits that determine its substrate specifi city and subcellular localization (Bollen, 2001; Cohen, 2002) .
Here, in order to detect changes in protein phosphorylation occurring in N2A cells when stimulated with Ang IV, we used a quantitative strategy based on stable isotope labeling of amino acids in cell culture (SILAC) to generate a phosphoproteome of N2A cells. This study showed that the phosphorylation status of many proteins changes upon Ang IV stimulation. Among these protein, PP1 and its relative proteins drew our great interest. We found that Ang IV stimulation reduced the phosphorylation level at its Thr320 residue. At the same time, spinophilin, one of its regulatory subunits, was found to have an increased expression and an augmented accumulation on peri-membrane and nucleus area. As a result, Ang IV up-regulates PP1's ac-ity of PP1α and play an important part in cell cycle regulation (Berndt, 1999; Li et al., 2007) .
To further confirm the regulation of PP1α by Ang IV, we investigated its phosphorylation level by Western blotting using an anti-phospho-PP1α antibody. We incubated N2A cells with 10 nmol/L Ang IV for 30 min, and detected phosphorylated PP1α by immunoblotting with a Phospho-PP1α (Thr320) specific antibody. A significant decrease (nearly 27% compared to the basal condition) in phosphorylation was observed ( Fig. 1E and 1F ), indicating the potential of Ang IV to up-regulate the activity of PP1α.
Ang IV increases the expression of spinophilin and changes its subcellular location
In addition to being directly suppressed by phosphorylation, tivity towards many of its substrates. This effect causes many changes such as proliferation and cell cycle arrest in neuronal cells.
RESULTS

Ang IV decreases phosphorylation of PP1α at Thr320
In order to systematically examine the changes in protein phosphorylation which occur when Ang IV acts on N2A cells, we performed a global SILAC-based quantitative phosphoproteome of N2A cells (Fig. 1A) . Examination of the resulting data drew our attention to one especially interesting phosphorylation event, a 0.24-fold decrease in the phosphorylation of the Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PPP1α) at Thr320 after 30 min of Ang IV stimulation (Fig. 1B-D) . The phosphorylation at this site is reported to inhibit the activ- PP1α is phosphorylated by cyclin-dependent kinase CDK1 and CDK2 on Thr320, and this inhibition is essential for cells to enter the S phase (Liu et al., 1999) . Moreover, a similar G 1 / S cell arrest occours when a constitutively activate mutant of PP1α (T320A) is induced in cells (Berndt et al., 1997) .
Ang IV dephosphorylates p70 S6K and pRB
In all euk aryotic cells, the progression of cell growth is driven PP1's activity towards its numerous targets is regulated by its interactions with a large number of regulatory subunits (R subunits) which target PP1α to distinct subcellular locations and specifi c targets (Terry-Lorenzo et al., 2002) . Spinophilin (spn, neurabin II), one of these PP1 regulatory proteins, has been shown to perform important functions in the nervous system, altering spine morphology and density, synaptic plasticity and neuronal migration (Allen et al., 1997; Ragusa et al., 2010) . Using immunoblotting, we found that after treatment with 10 nmol/L Ang IV for 4 h, the expression of spn increased to approximately 1.3-fold that of the control ( Fig. 2A and 2B ).
Immunofl uorenscence results showed that spn is enriched in the cell peri-membrane area of N2A cells where it colocalizes with F-actin, and accumulates in nuclei (Fig. 2C ). Interestingly, after cells were treated with Ang IV for 2 h, the amount of spn at both these two subcellular locations increased signifi cantly ( Fig. 2C ). It has been reported that when phosphorylated on two serine sites, spn dislocates from the membrane-associated fraction to the cytosol (Hsieh-Wilson et al., 2003) . This altered distribution of spn may refl ect the ability of Ang IV to regulate its post translational modifi cation.
Ang IV inhibits cell proliferation and arrests the cell cycle
The signifi cant changes in spn drew our attention to its other biological functions, such as that in cell growth, as it appears to be a strong growth suppressor in colony formation effi ciency (CFE) assays (Vivo et al., 2001) . We tested the effect of Ang IV on the proliferation of neuronal cells. N2A cells were cultured in 96-well plates and treated with different amounts of Ang IV. After 20 h, the number of cells in each group was counted with a cell counting kit-8(CCK8). The proliferation rate of cells treated with 10 nmol/L, 100 nmol/L, and 1000 nmol/L Ang IV decreased to ~0.89, ~0.85 and ~0.76, respectively ( Fig. 3A) , demonstrating that Ang IV inhibits proliferation of these cells. We also tested this effect on other cells; HEK293 cells which are reported to have no IRAP expression, and L6 rat myoblasts that express normal IRAP. We also established a stable cell line from L6 cells called 2F1, which expresses abundant exogenous IRAP (Fig. 3B ). Intriguingly, we found that the more IRAP expressed in a given cell line, the greater the effect of Ang IV on inhibiting its proliferation (Fig. 3C ). This decrease in cell proliferation suggested the possible involvement of a cell cycle delay at certain steps. We therefore examined whether Ang IV stimulation can cause cell cycle arrest and which phase is affected. After incubating with 10 nmol/L Ang IV for 20 h, we found that the percentage of N2A cells in G 1 /S phase increased significantly compared to the control group, while the percentage of cells in the G 2 phase decreased at the same time (Fig. 3D) . The same exp eriment was performed in HEK293 cells, but no signifi cant change was observed (data not shown). This cell cycle arrest at G 1 phase can be related to the decrease of phosphorylation at Thr320 of PP1α which we described above. In dividing mammalian cells, regulation of PP1 is crucial for maintaining a normal cell cycle. On stimulation with 10 nmol/L Ang IV for 4 h, the expression level of spn increased to 1.31 ± 0.13 (mean ± SD) fold that of the control (n = 5). (C) Immunofl uorescence assay showing that spn accumulates at both the peri-membrane and nucleus of N2A cells. Spn colocalizes with both F-actin stained with FITCphalloidin and nuclei labeled by DAPI. (D) On Ang IV stimulation, more spn was detected in both the nucleus and peri-membrane (1.34 ± 0.17 and 1.09 ± 0.02 (mean ± SD) fold increases relative to the control, respectively), as determined by fl uorescence intensity of spn in these two areas. Using Western blotting with an antibody against phosphorylated pRB (S807), we found that the phosphorylation level of pRB in cells is normal. After incubated with Ang IV for 30 min, however, the phosphorylation level of pRB is significantly decreased, to 79% of the control ones ( Fig. 4C and 4D ).
DISCUSSION
The classical renin-angiotensin system (RAS) cons ists of circul ating rennin which acts on angiotensinogen to produce Ang I, which in turn is converted into Ang II by angiotensin-converting enzyme ACE. Other RAS peptides generated from Ang II, including Ang III, Ang IV and Ang 1-7, ha ve been shown to be biologi cally active (Chansel et al., 1998) . Recent studies suggest that Ang IV has important regulatory functions in cognition, renal metabolism and cardiovascular damage, as well as in regulating cell growth in cardiac fibroblasts, endothelial cells and vascular smooth muscle cells Ruiz-Ortega et al., 2007) . The normal physiological level of Ang IV is about 8.6 ± 1.1 pg/mL in human serum and exerts its function via specifi c Ang IV receptors (Shibasaki et al., 1999) . This biologically active peptide has attracted increasing interest following by multiple phosphorylations of key regulatory proteins. The level of phosphorylation of these proteins determines whether the cell will proliferate, withdraw from the cell cycle, or die. To investigate how Ang IV causes such changes in cell progress, we examined some of these related proteins regulated by PP1. P70 S6K is a key enzyme involved in cell proliferation and cell cycle regulation. This kinase is activated by multiple stimuli including mitogens, insulin and serum (Chung et al., 1994; Chou and Blenis, 1995) . It has been reported that P70 S6K interacts competitively with PP1 for spn. By dephosphorylating P70 S6K , PP1 inactivates this kinase and dissociates it from spn (Burnett et al., 1998) . The ability of Ang IV to decrease cell proliferation led us to examine the activity of P70 S6K under Ang IV stimulation. Western blotting results showed that, after treatment with 10 nmol/L Ang IV, the phosphorylation level of P70 S6K is significantly lower than in control cells ( Fig. 4A and 4B ). Dephosphorylation of retinoblastoma protein pRB, a tumor suppressor protein, is thought to play a critical role in controlling the G 1 /S transition. PP1α is proved to be the dominant modulator in this process. In late G 1 , PP1 is inhibitorily phosphorylated by CDK on Thr320, thus loses its activity to maintain pRB in hypophosphorylation status. This step is crucial for cells to enter the S phase (Dou et al., 1995; Liu et al., 1999) . In view of this, we examined the phosphoryla- the discovery and cloning of IRAP, a binding site and a probable receptor (AT4) of Ang IV. Our study demonstrates that Ang IV has an inhibitory effect on proliferation of neural cells. We tested Ang IV's effect on cell proliferation in HEK293, N2A and 2F1 cell lines which express no, medium levels and high levels of IRAP, respectively. In line with their IRAP level, Ang IV barely, slightly and markedly inhibited their growth, demonstrating that this effect is dependent of IRAP. Transient protein modification is an essential regulatory mechanism for many biological processes. One type of transient modification, phosphorylation, is predicted to occur on nearly one-third of the proteins encoded in the human genome (Ceulemans and Bollen, 2004) . The fully sequenced human genome contains about 30 putative protein Ser/Thr phosphatases (PSPs), which comprise three major families: phosphoprotein phosphatases (PPPs), metal-dependent protein phosphatases (PPMs), and aspartate-based phosphatases represented by FCP/SCP (Shi, 2009) . PP1 is a representative member of the PPP family and is universally expressed in all eukaryotic cells. It plays an important part in a wide range of cellular processes, including apoptosis, membrane receptor and channel regulation, meiosis and cell division, protein synthesis, and cytoskeletal reorganization (Cohen, 2002; Ceulemans and Bollen, 2004) . In the nervous system, PP1 regulates short-term events such as the phosphorylation status of receptors, ion channels, and signaling proteins, as well as long term events requiring changes in protein synthesis, gene expression, and neuronal morphology that together modify neuronal plasticity (Gräff et al., 2010) .
The activity of PP1 can be regulated directly by proteins like CDKs which inhibit PP1 via phosphorylating its Thr320 site. Another mechanism by which PP1 achieves its precise substrate specifi city is by combining many kinds of regulatory subunits (Bollen, 2001; Cohen, 2002) . Spinophilin/neurabin II (spn) is one of these regulatory subunits and directs the catalytic subunit of this PP1 (PP1c) close to some of its substrates (Satoh et al., 1998; Sarrouilhe et al., 2006) . Morphological studies established that spn is enriched at the plasma membrane of cells although the protein is also expressed widely throughout the cytoplasm (Smith et al., 1999; Tsukada et al., 2003) . Intriguingly, when two serines in and near the NH 2 -terminal actin binding domain of spn are phosphorylated, the spn/PP1 complex tends to dissociate from the membraneassociated fraction to the cytosol (Hsieh-Wilson et al., 2003) . Our results indicate that spn changes its localization in the cell when stimulated with Ang IV. This re-distribution could target PP1 to some certain of its substrates, resulting in changes in cellular behavior. We also found that the putative AT4 receptor IRAP is involved in the regulation of PP1 and spn. In 2F1 cells, spn was found to have an increased expression after treated with Ang IV. At the same time, the phosphorylation level of PP1 at Thr320 was inhibited. These changes are exactly the same as happened in N2A cell. But no such phenomenon was detected in HEK293 cells (Fig. S1) .
Many reports have shown that PP1 and spn take part in regulating cell proliferation via P70 S6K , the activation of which is important for progression through G 1 (Chou and Blenis, 1995) . An interaction between spn and P70 S6K has been demonstrated in vitro (Buchsbaum et al., 2003) . Interestingly, the binding of PP1 and P70 S6K to spn is mutually exclusive, probably because PP1 and the kinase compete for overlapping binding sites, or PP1 activity prevents P70 S6K kinase from binding (Burnett et al., 1998) . When associated with spn, PP1 dephosphorylates P70
S6K
, therefore inhibiting its activity and dissociating it from spn/PP1. A similar mechanism is found in the vitamin D receptor mediated pathway, where ligand-activated PP1 dephosphorylates P70 S6K , thus inactivating it and preventing its recruitment from this receptor. This process is argued to contribute to vitamin D-induced cell cycle arrest (Bettoun et al., 2002) . Our results also show that, as PP1 activity is upregulated, the phosphorylation level of P70 S6K decreases, even though increased expression of spn was detected. This may explain the observed effect of Ang IV on inhibiting N2A cell proliferation and the resulting cell cycle arrest. Another important protein which plays a key role in the regulation of the cell cycle is pRB. pRB is dephosphorylated during mitosis, and the active, hypophosphorylated form inhibits cell cycle progression during early and mid-G 1 . PP1 has been implicated as the major pRB phosphatase in vivo (Yan and Mumby, 1999) . This has been clearly demonstrated as a constitutively active T320A mutant of PP1α prevents retinoblastoma protein Rb phosphorylation in late G 1 cells and causes cell cycle arrest (Berndt et al., 1997) . On the other hand, loss of spn reduces levels of PPP1CA, resulting in the retention of (mean ± SD) that of the control after treatment with 10 nmol/L Ang IV for 30 min (n = 6). (C and D) P-pRB decreased to 0.79 ± 0.08 (mean ± SD) fold that of the control after Ang IV stimulation (n = 6). Two specifi c bands may also refl ect a different modifi cation status of this protein.
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& hyperphosphorylated pRB (Molina-Pinelo et al., 2011) . In our research, Ang IV had the ability to delay the cell from entering S phase, causing a G 1 /S cell arrest. This phenomenon is consistent with decreased pRB phosphorylation compared to the control. This is most probably due to up-regulation of PP1α with its Thr 320 site dephosphorylated. At the same time, pRB is a well-known substrate of CDKs. In mammalian cells, RB-family proteins could be phosphorylated by cyclin-D-CDK4/6 Kato et al., 1993) and cyclin-E-CDK2 (Akiyama et al., 1992; Hinds et al., 1992) cooperatively. Phosphorylation of the pRB family proteins by CDKs during G 1 phase causes pRB to derepress E2Fs, allowing the transcription of E2F target genes that stimulate progression into S phase (Dyson, 1998) . So, there is another possibility that Ang IV may decrease the phosphorylation level of pRB indirectly by inhibiting the activity of CDK. In fact, many CDK inhibitors (CKIs) do play an important role in arresting the cell cycle in G 1 phase. So, the relationship between Ang IV and CDKs remains to be further investigated.
Here, we have described a complex relationship between Ang IV stimulation and PP1 activity in neuronal cells. We propose that addition of Ang IV increases the activity of PP1 by increasing spn expression and decreasing its inhibitory phosphorylation at Thr320. Accordingly, the phosphorylation level of some certain proteins is down-regulated. This function may be directly mediated by the raised activity of PP1, or indirectly by inhibiting the activity of some protein kinases, such as CDKs. By doing so, Ang IV could regulate the proliferation of neuronal cells.
MATERIALS AND METHODS
Antibodies and reagents
Spinophilin (Neurabin II) antibody was purchased from Santa Cruz biotechnology, and β-actin, PP1α, Phospho-PP1α (Thr320), p70 S6K , Phospho-p70S6 (Thr389) kinase and HRP (horseradish peroxidase)-conjugated secondary antibody were purchased from Cell Signaling Technology. Rb and Phospho-Rb (S807) were purchased from Bioworld Technology, Inc. FITC-labeled phalloidin, CY5 combined antirabbit second antibody, DAPI and propidium iodide were purchased from Invitrogen, USA. Western Lightning Plus-ECL enhanced chemiluminescence substrate was obtained from PerkinElmer. Ang IV (ValTyr-Ile-His-Pro-Phe-OH) was obtained from Bach em (Bubendorf, Switzerland). Cell Counting Kit-8 (CCK8) was purchased from Dojindo Molecular Technologies, Inc, Japan. L-Arginine:HCl (U- N 2 ) were from Cambridge Isotope laboratories Inc., Andover MA. Dialyzed FBS was purchased from Biological Industries (Kibbutz Beit Haemek, Israel).
Cell culture
N2A cells, L6 cells and HEK293 cells were cultured in DMEM/F12, α-MEM and DMEM medium (Gibco), respectively, with 10% fetal bovine serum (Hyclone) in a 37°C incubator with 5% CO 2 .
SILAC and sample preparation for LC-MS/MS analysis
A SILAC strategy was used for quantitative phosphoproteome analysis as previously described (Cui et al., 2009) . Briefl y, N2A cells were cultured in DMEM/F12 supplemented with 8% dialyzed FBS plus 2% normal FBS and light (L) or heavy (H) arginine and lysine isotopes. Labeling of cells was performed for at least seven population doublings. After labeling effi ciency reached more than 98%, cells with different labels were respectively treated with/without 10 nmol/L Ang IV for 30 min. After washing with ice-cold PBS, cells were scraped into 8 mol/L urea containing a protease inhibitor cocktail and phosphatase inhibitor (Roche, Basel, Switzerland), and were sonicated to lyse the cells. After centrifugation for 30 min at 20,000 g in a bench-top centrifuge (Thermo Fisher Scientifi c, Waltham, MA), the supernatants were collected and protein concentrations were measured using the Pierce BCA protein assay according to the manufacturer's protocol. Protein extracts from L and H cells were adjusted to an equal protein concentration and then mixed at a 1:1 ratio. Protein mixtures were then reduced with 10 mmol/L DTT for 1 h, and alkylated with 40 mmol/L iodoacetamide in the dark for 45 min at room temperature. 40 mmol/L DTT was added to quench the iodoacetamide for 30 min at room temperature. After diluting 8 mol/L urea to 1.6 mol/L with 25 mmol/L NH 4 HCO 3 , sequence grade trypsin was added at a ratio of 1:50 (enzyme: protein) and proteins were then digested at 37°C overnight. Tryptic digestion was stopped by adding formic acid to a fi nal concentration of 1%. The protein digests were separated fi rst into 9 fractions with self-packed C18 columns and then each fraction was submitted to TiO 2 phosphopeptide enrichment. The resulting phosphopeptides were combined and analyzed using an online 2D-LC-MS/MS on a LTQ Orbitrap mass spectrometer (Thermo Scientifi c) as described (Hou et al., 2010) . Spectra were interpreted using MaxQuant version 1.3.0.5.
Cell proliferation assays
Cells were cultured in 96-well plates to a total volume of 90 mL and 30% density. Serial dilutions of Ang IV were added to different wells, and incubated for 18 h. 10 mL of CCK8 reaction solution was added to each well and incubated at 37°C for 1 h. Absorption at 630 nm was detected to determine cell density in each well.
Immunoblotting
N2A cells were serum-starved for at least 6 h before treatment with 10 nmol/L Ang IV. After the times indicated, they were washed twice with PBS and harvested with SDS sample buffer (50 mmol/L Tris-HCl (pH 6.8), 10 mmol/L DTT, 2% SDS, 0.025% bromophenol blue, 12.5% glycerol). Proteins were separated by SDS-PAGE and electrotransferred to nitrocellulose membranes, then detected by immunoblotting with the antibodies indicated, followed by HRP (horseradish peroxidase)-conjugated secondary Abs. β-actin was assayed to ensure equal loading of total protein in each lane. Immunoreactive bands were visualized with Western Lightning Plus-ECL enhanced chemiluminescence substrate as indicated, and densitometric analyses were carried out using ImageJ (NIH).
Cell cycle analysis
HEK293 and N2A cells were cultured as described above. Treated
